Manager × security

Stablepoint Partners, LLC CVS holdings history

Who else holds this security? →

CVS HEALTH CORP · CUSIP 126650100 · CIK 2011237

Citable facts

As of Sep 30, 2026, Stablepoint Partners, LLC reported 76.18K CVS (shares), valued at $6.53M, or 0.88% of its reported non-derivative portfolio. Filed Nov 3, 2026.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.88%
Shares
76.18K
76,180
Reported value
$6.53M
USD

Shares decreased 13.78%; reported value decreased 28.58%, and weight changed -0.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q3 20260.88%76,180SEC filing ↗Filed Nov 3, 2026
Q2 20261.26%88,359SEC filing ↗Filed Jul 9, 2026
Q1 20260.94%88,169SEC filing ↗Filed Apr 30, 2026
Q4 20251.14%91,951SEC filing ↗Filed Jan 13, 2026
Q3 20251.10%91,861SEC filing ↗Filed Nov 3, 2025
Q2 20251.17%99,410SEC filing ↗Filed Aug 13, 2025
Q1 20251.21%98,316SEC filing ↗Filed Apr 11, 2025
Q4 20240.63%76,741SEC filing ↗Filed Jan 21, 2025
Q3 20240.98%85,849SEC filing ↗Filed Oct 11, 2024
Q2 20241.04%87,325SEC filing ↗Filed Aug 2, 2024
Q1 20241.21%74,766SEC filing ↗Filed Apr 23, 2024
Q4 20231.46%71,980SEC filing ↗Filed Feb 12, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20231.46%71,980$5.68MA comparable prior-quarter record is unavailable; changes are not inferred.SEC filing ↗
Filed Feb 12, 2024
Q1 20241.21%74,766$5.96MShares increased 3.87%; reported value increased 4.92%, and weight changed -0.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 23, 2024
Q2 20241.04%87,325$5.38MShares increased 16.80%; reported value decreased 9.84%, and weight changed -0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 2, 2024
Q3 20240.98%85,849$5.40MShares decreased 1.69%; reported value increased 0.40%, and weight changed -0.06 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 11, 2024
Q4 20240.63%76,741$3.44MShares decreased 10.61%; reported value decreased 36.18%, and weight changed -0.35 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 21, 2025
Q1 20251.21%98,316$6.66MShares increased 28.11%; reported value increased 93.36%, and weight changed +0.58 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 11, 2025
Q2 20251.17%99,410$6.86MShares increased 1.11%; reported value increased 2.95%, and weight changed -0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2025
Q3 20251.10%91,861$6.93MShares decreased 7.59%; reported value increased 0.99%, and weight changed -0.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 3, 2025
Q4 20251.14%91,951$7.30MShares increased 0.10%; reported value increased 5.37%, and weight changed +0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 13, 2026
Q1 20260.94%88,169$6.33MShares decreased 4.11%; reported value decreased 13.22%, and weight changed -0.20 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 30, 2026
Q2 20261.26%88,359$9.14MShares increased 0.22%; reported value increased 44.35%, and weight changed +0.32 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 9, 2026
Q3 20260.88%76,180$6.53MShares decreased 13.78%; reported value decreased 28.58%, and weight changed -0.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 3, 2026
Stablepoint Partners, LLC · CVS HEALTH CORP

Take these holdings further.

This page includes 12 of 12 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_institutional_holdings
{"action":"portfolio","cik":"2011237","quarter":"2026Q3","cusip":"126650100"}

akkru_institutional_holdings
{"action":"history","cik":"2011237","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP / CLI documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.